We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Here you can view the programme http://fetalmedicine.org/var/uploads/File/0/0/2/1/2014-FETAL-MEDICINE-BOOKLET.pdf
Should get news on this event soon,have a feeling it went well. 13th World Congress on Fetal Medicine, Nice, France. 29th June – 3rd July 2014. Premaitha is exhibiting at the 13th World Congress on Fetal Medicine. So please visit us on Stand No.1.
Yes buying no probs now as they've increased the spread......not playing those games. Still good value under .2 all the same
Anyone buy?
This is moving back up quick..19p buyers. Not sure what method some of you use to buy shares. I have never had a problem buying any. I use a broker & put a limit on my order,if its not enough i then increase it.
sorry. 0.1723 they will take mine but still not allowed to buy. Do they know something we don't ?
Mm's gathering shares for impending demand? Can't think of anything else...everyone holding and waiting for release and consolidation and major rerating. I wouldn't be selling either under any circumstances
Am with Lloyds. They will buy my shares at 0.175 but wont sell me any. Gone as low as 10000 still nothing
Morning Same for me with HL No buy price, even for 100 quid
I am using barclays cant buy either, but can sell 2.4 m for 0.17. Just a treeshake at the mo
Maybe a tech glitch as spread is now 0.173/0.185, try again.
Can't buy on HL this morning anybody else having problems
Volume is quite low,not enough sellers. Nothing wrong with a NT trade. Why not put a limit order on it & you should get what you want.
Have been trying since it opened to buy but it will only go NT
Chance to get some cheap shares,down on low volume.
Have a feeling that it will be done by Friday ready for the placement of new shares and maybe a nice snipet of news with it!
When whoever is buying big has finished we will see a large sustained upward movement in the sp ... Seen it so many times on Aim in the past!!
AIM listed Vialogy (VIY) shares came back from suspension on Friday, closing the session at 0.16p after a £6.5 million placing at 0.11p. We took part in that placing and will be taking up our full entitlements in the open offer at 0.11p – we were already shareholders. I suggest that existing shareholders do the same (given how in the money they are already) and also buy a lot more in the market on Monday. Vialogy has bought molecular diagnostic company Premaitha by issuing 95 million shares at 0.11p (that is a £10.5 million price tag). It has raised another £6.5 million at 0.11p in a placing which was FOUR TIMES oversubscribed with a raft of institutions on board. The open offer will raise up to £700,000 more. Effectively the free float (since the vendors and institutions and those who backed the last placing cannot or will not flip) is c 10%, if that. The board now comprises the company rescuer Adam Reynolds, Stephen Little from Premaitha who is a very impressive chap but also David Evans. Do you remember Axis Shield? No wonder the funds were lining up to back this one. Premaitha is working on the final development and commercialisation of a non-invasive pre-natal screening test for Down's syndrome developed by Premaitha. This is a massive market. Assuming the Open Offer is fully taken up the market cap at 0.11p (there will be a 100 for 1 consolidation) is sub £20 million. At 0.15p it is c£27 million and the company will have cash of c£8 million. An £19 million EV for a company with this board set to tap into a market this big ($4.2 billion) looks far too low. This is not a classic value investment of the sort Steve Moore and I favour. There are obvious risks. But we chatted to Reynolds who seems confident that his generous 0ption package (priced at 0.1p) will kick in before very long. That would require the shares to trade at above 0.5p for 30 consecutive days. With an undemanding EV, a tight free float and Evans on board, I really would not bet against it. We will only sell 24 hours after giving Nifty Fifty readers advice to bank gains. Our initial target price is a cautious 0.36p to sell. - See more at: http://www.shareprophets.advfn.com/views/5994/vialogy-reverse-takeover-placing-shares-unsuspended-strong-buy#sthash.onjsWnam.dpuf
Two things I've taken from this: "Routine contact with hospital staff" = targeting NHS "it will create a world in which all pregnant women can have accurate and safe information about their pregnancy." = targeting NHS The role will be varied, with a combination of office based clinical administration work (~70%) and field based data monitoring work (~30%). There will be no direct contact with patients but the successful applicant will have routine contact with hospital staff (i.e. Research midwives and consultants) About Premaitha Health Ltd Premaitha uses leading cutting edge technology in the field of diagnostics to bring a new product to market. Premaitha's vision is that by making it's technology widely available to testing laboratories, it will create a world in which all pregnant women can have accurate and safe information about their pregnancy. Premaitha Health is lead by experienced and dynamic Executive and Non-Executive teams, with a wealth of expertise in developing and commercialising molecular diagnostics. The field of Fetal Medicine is a fast, friendly environment to work in and the successful applicant will join a small, hardworking team of friendly and sociable staff.
Hello buddy, help you are well. Feel for ya re the losses, never good. The ONLY person left from the old set up is Mark C, the others have all gone. It's terrible what the old co did but please try and ring fence that in your head - it's gone. Reynolds is a top top business man and put his own money in - he has said to SFU that it's the best deal he has done and if u look at his track record that is a bold statement! I sincerely hope this gets ya some of your bugs bunny back.
Adam Reynolds is the key guy that will make this company,he is competent in this sector. Some of the old board members who where holding it back are now gone.
I did all the research on both the old and the "new" VIY!!! What went before does matter and I am aware of all that has transpired. Reynolds obviously knows a lot about the old VIY too.
Why not do some research & come back to us with what you find. What went before does not mater as they have a new director & new board members. The clown who fleeced the company to line his own pockets is gone.
some of the reds are in fact buys!
All blue.... GOOD yes ???